In 2003, Congress passed the Medicare Modernization Act (MMA), which created an outpatient prescription drug benefit in the Medicare program. Known as Part D, the prescription benefit is operated exclusively through private insurance plans that contract with Medicare. To ensure that beneficiaries have coverage for the drugs they need Part D plans are required to cover at least two drugs in each therapeutic class. A therapeutic class is a group of medications that are used to treat the same condition.
Overall Cancer Costs are Rising
The U.S. spent approximately $183 billion on cancer-related health care in 2015. This represents a signification portion of the total health care spending in the U.S. And it is expected to keep growing. By 2030 cancer-related health care spending is expected to reach nearly $246 billion. These high costs are paid by many people – individual cancer patients and their families, employers, insurance companies and taxpayers.
ACS CAN Fights for Solutions
ACS CAN wants to ensure that all individuals can afford the right health care services at the right time, no matter where they are in their cancer journey. This includes preventive services, cancer screenings, cancer therapy and survivorship care. To make this happen, policymakers must focus on ensuring affordable access to insurance coverage and health care services, and reducing the overall financial impact of cancer for patients and families. Policymakers can also limit costs of cancer by pursuing policies that promote cancer prevention and early detection.